Although NTRK fusions were detected in WT GISTs at a low frequency, patients with GIST presenting NTRK fusions had a good chance of responding to treatment with TRK inhibitors, particularly patients with recurrent tumors that are resistant to TKIs. The gene discussed is NTRK1; the disease is gastrointestinal stromal tumor.